U.S. flag

An official website of the United States government

NM_013254.4(TBK1):c.229-4dup AND Glaucoma 1, open angle, P

Germline classification:
Benign (2 submissions)
Last evaluated:
Jul 30, 2015
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000625058.6

Allele description [Variation Report for NM_013254.4(TBK1):c.229-4dup]

NM_013254.4(TBK1):c.229-4dup

Gene:
TBK1:TANK binding kinase 1 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
12q14.2
Genomic location:
Preferred name:
NM_013254.4(TBK1):c.229-4dup
HGVS:
  • NC_000012.12:g.64464330dup
  • NG_046906.1:g.17271dup
  • NM_013254.4:c.229-4dupMANE SELECT
  • LRG_1306t1:c.229-4dup
  • LRG_1306:g.17271dup
  • NC_000012.11:g.64858100_64858101insT
  • NC_000012.11:g.64858110dup
  • NM_013254.3:c.229-4dupT
Links:
dbSNP: rs57810028
NCBI 1000 Genomes Browser:
rs57810028
Molecular consequence:
  • NM_013254.4:c.229-4dup - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Glaucoma 1, open angle, P
Identifiers:
Gene: 101448070; MONDO: MONDO:0008328; MedGen: C3888338; OMIM: 177700

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000743634Genome Diagnostics Laboratory, University Medical Center Utrecht - VKGL Data-share Consensus
criteria provided, single submitter

(ACGS Guidelines, 2013)
Benign
(Jul 30, 2015)
germlineclinical testing

Citation Link,

SCV000745751Genome Diagnostics Laboratory, Amsterdam University Medical Center - VKGL Data-share Consensus
no assertion criteria provided

(ACGS Guidelines, 2013)
Benign
(Apr 22, 2016)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Genome Diagnostics Laboratory, University Medical Center Utrecht - VKGL Data-share Consensus, SCV000743634.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Genome Diagnostics Laboratory, Amsterdam University Medical Center - VKGL Data-share Consensus, SCV000745751.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 10, 2024